Background
Methods
The PredictD trial
The Spanish primary care context
Interventions
Intervention group
Control group
Economic analysis
Cost
Costs | Unit cost (€2012) | Mean costs, control (95% CI) | Mean costs,intervention (95% CI) | Unadjusted diff (95%CI)a | P value |
---|---|---|---|---|---|
Costs associated to the intervention | €0 | €4.79 | NA | NA | |
Primary care physician | €10.50 (centre visit),€27.48 (home visit) | €96.61 (90.54 to 102.68) | €91.46 (85.68 to 97.23) | €–5.16 (–13.58 to 3.27) | 0.230 |
Primary care nurse | €10.03 (centre visit),€25.37 (home visit) | €35.67 (28.74 to 42.59) | €26.34 (21.23 to 31.45) | €–9.32 * (–17.95 to –0.69) | 0.032 |
Social worker | €14.90 (centre visit),€25.37 (home visit) | €0.63 (0.41 to 0.87) | €0.46 (0.27 to 0.66) | €–0.18 (–0.51 to 15) | 0.293 |
Emergency visits to primary care | €63.99 | €33.07 (25.27 to 40.86) | €29.05 (22.20 to 35.90) | €–4.02 (–14.44 to 6.40) | 0.451 |
Total primary care | €162.75 (151.01 to 174.49) | €146.17 (135.76 to 156.58) | €–16.58 (–32.32 to –0.85) | 0.039 | |
Outpatient mental health (MH) visit | €42.93 (psychiatrist),€70.61 (psychologist),€10.03 (MH nurse),€19.22 (group therapy) | €16.16 (9.74 to 22.57) | €16.31 (8.08 to 24.54) | €0.15 (–10.31 to 10.62) | 0.997 |
Antidepressant |
*Different values*
| €20.70 (0 to 72.8) | €22.32 (0 to 76.77) | €1.62 (–57.74 to 60.98) | 0.658 |
Admission to psych.hospitalb | €284.90 | NA | NA | NA | NA |
Total mental health | €45.19 (31.02 to 59.36) | €34.40 (24.07 to 44.73) | €–10.79 (–27.11 to 5.54) | 0.184 | |
Other outpatient specialists | €51.08 | €149.08 (122.96 to 175.19) | €149.46 (122.53 to 176.40) | €0.38 (–35.26 to 36.02) | 0.973 |
Diagnostic tests |
*Different values*
| €212.86 (189.47 to 236.25) | €198.24 (176.59 to 219.89) | €–14.61 (–46.31 to 17.08) | 0.368 |
Emergency visits to hospital | €155.50 | €96.18 (73.13 to 119.24) | €92.82 (70.60 to 115.04) | €–3.37 (–34.20 to 27.47) | 0.831 |
Non-mental health-related admissions |
*Different values*
| €493 (134.79 to 852.27) | €548.04 (0 to 1136.96) | €54.51 (–141.48 to 250.50) | 0.587 |
Total healthcare direct costs | €1039.11 (819.24 to 1258.98) | €1075.11 (849.70 to 1300.53) | €36.01 (–132.02 to 204.04) | 0.676 | |
Sick leave | €21.11/day | €337.37 (122.08 to 552.68) | €335.30 (96.60 to 574.03) | €–2.08 (–126.1 to 121.94) | 0.974 |
Total costs | €1353.99 (1039.31 to 1668.66) | €1394.83 (1020.07 to 1769.6) | €40.85 (–178.21 to 259.91) | 0.716 | |
Units for sensitivity analysis | |||||
Extra intervention costsc |
0
| €31.72 | NA | NA | |
Private direct health costs |
*Different values*
| €174.13 (76.92 to 271.33) | €126.00 (82.90 to 169.10) | €–48.13 (–107.10 to 10.83) | 0.099 |
Absenteeism | €21.11/day | €87.34 (57.27 to 117.42) | €89.70 (63.38 to 116.01) | €2.35 (–30.66 to 35.37) | 0.888 |
Presenteeism | €21.11/day | €80.41 (36.78 to 124.04) | €63.39 (34.42 to 92.34) | €–17.02 (–52.93 to 18.81) | 0.322 |
Effects | Unit of the effect | Effect gained control (95% CI) | Effect gained intervention (95%CI) | Unadjusted diff (95%CI)a | P value |
QALYs | Mean | 1.22 (1.20 to 1.24) | 1.25 (1.23 to 1.26) | 0.03 (–0.02 to 0.07) | 0.240 |
QALYs-VAS | Mean | 1.05 (1.04 to 1.07) | 1.08 (1.07 to 1.10) | 0.03 (0.006 to 0.05)* | 0.014 |
Health effects
Statistical analysis
Sensitivity analyses
Results
Participants
Cost-effectiveness analyses
Effect | Ajdusteda mean difference (95% bootstrapped CI) and ICER |
---|---|
Main Outcome | |
Societal perspective | |
Incremental cost | –16.38(–615 to 503) |
Incremental QALY | 0.02(–0.00 to 0.04) |
ICER (cost per QALY gained) | Dominant |
National Health perspective | |
Incremental cost | 23.88 (–149 to 215) |
Incremental QALY | 0.02 (–0.00 to 0.04) |
ICER (cost per QALY gained) | €1327/QALY |
Secondary outcomes | |
Societal perspective | |
Incremental cost | –16.38(–615 to 503) |
Incremental QALY-VAS | 0.02 (0.01 to 0.03) |
ICER (cost per QALY-VAS gained) | Dominant |
National Health perspective | |
Incremental cost | 23.88 (–149 to 215) |
Incremental QALY-VAS | 0.02(0.01 to 0.03) |
ICER (cost per QALY-VAS gained) | €1085/QALY |
Sensitivity analysis
Sensitivity analysisa | Adjusted mean difference (95% CI ) and ICER | Incremental net benefit: probability intervention is seen as effective with a threshold of: | ||||
---|---|---|---|---|---|---|
€0 | €10,000 | €30,000 | €50,000 | €100,000 | ||
A. Perspective | ||||||
Costs only related to primary cre and mental health | ||||||
Incremental cost | €–43.61 (–186 to 10) | |||||
Incremental QALY | 0.02(–0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.9250 | 0.9852 | 0.9808 | 0.9784 | 0.9765 |
All the costs | ||||||
Incremental cost | €–10.32 (–253 to 281) | |||||
Incremental QALY | 0.02(–0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.537 | 0.8989 | 0.9659 | 0.9724 | 0.9751 |
B. Discount rate (societal perspective) | ||||||
Discount rate: 0% | ||||||
Incremental cost | €–16.19 (–612 to 500) | |||||
Incremental QALY | 0.02 (0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.5309 | 0.8347 | 0.9413 | 0.9606 | 0.9710 |
Discount rate: 6% | ||||||
Incremental cost | €–16.51 (–618 to 505) | |||||
Incremental QALY | 0.02(–0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.5316 | 0.8301 | 0.93855 | 0.9584 | 0.9694 |
C. Unit costs (societal perspective) | ||||||
Cost doubled | ||||||
Incremental cost | €–32.76 (–1231 to 1006) | |||||
Incremental QALY (social tariffs) | 0.02(–0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.5316 | 0.734 | 0.8874 | 0.9301 | 0.9594 |
Costs halved | ||||||
Incremental cost | €–8.19 (–308 to 252) | |||||
Incremental QALY (social tariffs) | 0.02(–0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.5316 | 0.9140 | 0.9635 | 0.9699 | 0.9734 |
D. Analytical strategy | ||||||
Seemingly unrelated equations (societal perspective) | ||||||
Incremental cost | €–38 (–251 to 174) | |||||
Incremental QALY (social tariffs) | 0.02(–0.00 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.6383 | 0 .9307 | 0.9711 | 0.9750 | 0.9767 |
Completers analysis (societal perspective)b | ||||||
Incremental cost | €–14.46 (–1217 to 1456) | |||||
Incremental QALY (social tariffs) | 0.02 (0.01 to 0.04) | |||||
ICER (cost per QALY gained) | Dominant | 0.48 | 0.761 | 0.888 | 0.923 | 0.962 |
Models adjusted only by costs or QALYs at baseline (societal perspective) | ||||||
Incremental cost | €118.52 (–909€ to 1497) | |||||
Incremental QALY (social tariffs) | 0.02 (0.01 to 0.04) | |||||
ICER (cost per QALY gained) | €5644/QALY | 0.3864 | 0.7165 | 0.8727 | 0.9218 | 0.9606 |